COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 2012: Articles 20111-20120  | Next

Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence
Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., O'Hehir, R. E., van Zelm, M. C.
10.1101/2020.11.17.20233544 — Posted: 2020-11-20 Discussion: Onsite
Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients.
Boshier, F. A. T., Pang, J., Penner, J., Hughes, J., Parker, M., Shepherd, J. G., Alders, N., Bamford, A., Grandjean, L., Grunewald, S., Hatcher, J., Best, T., Dalton, C., Bynoe, P. D., Frauenfelder, C., Koeglmeier, J., Myerson, P., Roy, S., Williams, R., The COVID-19 Genomics UK (COG-UK) Consortium, , Thomson, E. C., de Silva, T. I., Goldstein, R. A., Breuer, J.
10.1101/2020.11.18.20230599 — Posted: 2020-11-20
Secondary Attack Rate (SAR) in household contacts of expired primary cases of COVID-19: A study from Western India
Shah, K., Desai, N., Mavalankar, D.
10.1101/2020.11.17.20231290 — Posted: 2020-11-20
REACT-1 round 6 updated report: high prevalence of SARS-CoV-2 swab positivity with reduced rate of growth in England at the start of November 2020
Riley, S., Ainslie, K. E. C., Eales, O., Walters, C. E., Wang, H., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2020.11.18.20233932 — Posted: 2020-11-20
Cov-MS: a community-based template assay for clinical MS-based protein detection in Sars-Cov-2 patients
Van Puyvelde, B., Van Uytfanghe, K., Tytgat, O., Van Oudenhove, L., Gabriels, R., Bouwmeester, R., Daled, S., Van Den Bossche, T., Ramasamy, P., Verhelst, S., De Clerck, L., Corveleyn, L., Debunne, N., Wynendaele, E., De Spiegeleer, B., Judak, P., Roels, K., De Wilde, L., Van Eenoo, P., Reyns, T., Cherlet, M., Dumont, E., Debyser, G., t'Kindt, R., Sandra, K., Gupta, S., Drouin, N., Harms, A., Hankemeier, T., Jones, D., Gupta, P., Lane, C., El Ouadi, S., Vincendet, J.-B., Morrice, N., Oehrle, S., Tanna, N., Silvester, S., Hannam, S., Sigloch, F., Bhangu-Uhlmann, A., Claereboudt, J., Razavi, M., Anderson, N. L., Degroeve, S., Cuypers, L., Stove, C., Lagrou, K., Martens, G. A., Deforce, D., Martens, L., Vissers, H., Dhaenens, M.
10.1101/2020.11.18.20231688 — Posted: 2020-11-20
Biofunctionalized Two-dimensional MoS2 Receptors for Rapid Response Modular Electronic SARS-CoV-2 and Influenza A Antigen Sensors
Muratore, C., Muratore, M. K., Austin, D. R., Look, P., Benton, A. K., Beagle, L. K., Motala, M. J., Moore, D. C., Brothers, M. C., Kim, S. S., Krupa, K., Back, T. A., Grant, J. T., Glavin, N. R.
10.1101/2020.11.17.20233569 — Posted: 2020-11-20
Quantifying Covid19-Vaccine Location Strategies For Germany
Leithaeuser, N., Schneider, J., Johann, S., Krumke, S., Streicher, M., Schmidt, E., Scholz, S.
10.1101/2020.11.18.20234146 — Posted: 2020-11-20
Detecting SARS-CoV-2 variants with SNP genotyping
Harper, H., Burridge, A. J., Winfield, M., Finn, A., Davidson, A. D., Matthews, D., Hutchings, S., Vipond, B., Jain, N., Edwards, K. J., Barker, G., The COVID-19 Genomics UK (COG-UK) consortium
10.1101/2020.11.18.388140 — Posted: 2020-11-19
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
Fareh, M., Zhao, W., Hu, W., Casan, J. M., Kumar, A., Symons, J., Voskoboinik, I., Ekert, P. G., Rudraraju, R., Lewin, S. R., Trapani, J. A.
10.1101/2020.11.18.389312 — Posted: 2020-11-19
Acute nasal dryness in COVID-19
Navarra, J., Ruiz-Ceamanos, A., Moreno, J. J., Garcia-Basterrechea, J. M., de Haro-Licer, J., Sinnett, S., Spence, C., Gallardo-Pujol, D.
10.1101/2020.11.18.20233874 — Posted: 2020-11-19 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).